Given the increasing numbers of refugees worldwide, the prevalence of their mental
disorders is relevant for public health. Prevalence studies show that, in the first years of …

Substance use is a major cause of disability globally. This has been recognized in the recent
United Nations Sustainable Development Goals (SDGs), in which treatment coverage for …

Aims To examine patient and medication characteristics associated with retention and
continued illicit opioid use in methadone (MET) versus buprenorphine/naloxone (BUP) …

Aims To examine changes in the evidence on the adverse health effects of cannabis since
1993. Methods A comparison of the evidence in 1993 with the evidence and interpretation of …

Background and aims Drug abuse is a significant social and public health problem in Iran.
The present study aimed to provide prevalence estimates and information on correlates of …

Background Buprenorphine maintenance treatment has been evaluated in randomised
controlled trials against placebo medication, and separately as an alternative to methadone …

Although the medicinal properties of Cannabis species have been known for centuries, the
interest on its main active secondary metabolites as therapeutic alternatives for several …

Background The aim of the current study was to investigate the association between anxiety
and cannabis use/cannabis use disorders in the general population. Methods A total of N …

Objective To quantify the effect of opiate substitution treatment in relation to HIV transmission
among people who inject drugs. Design Systematic review and meta-analysis of prospective …

Background Studies have shown a high degree of comorbidity between cannabis use
disorder (CUD) and other mental illnesses. However, there is a paucity of research on the …